1O'agan DT,ackichan ML,Singh M.Recent developments in adjuvants for vaccines against infectious diseases.Biomol.Eng.,2001,18(3):69～85
2Aucouturier J,Dupuis L,Ganne V.Adjuvants designed for veterinary and human vaccines.Vaccine,2001,19(17/19):2 666～2 672
3Barr IG,Sjolander A,Cox JC.ISCOMs and other saponin based adjuvants.Advanced drug delivery reviews,1998,32(3):247～271
4Shigeji Katayama,Kenji Oda,Toshiaki Ohgitani,et al.Influence of antigenic forms and adjuvants on the IgG subclass antibody response to Aujeszky's disease virus in mice.Vaccine,1999,17:2 733～2 739
5Wu JY,Gardner B,Murphy CI,et al.Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1vaccine.J.Immunol.,1992,148:1 519～1 525
6Shashi B.Mahato,Sucharita Sen.Advances in triterpenoid research,1990～1994.Phytochemistry,1997,44 (7):1 185～1 236
7D.J.Marciani,J.B.press,R.C.Reynolds,et al.Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity.Vaccine,2000,18:3 141～3 151
8Ma J N,Bulger P A,Dante S,et al.Characterization of canine hrmoral immune responses to outer surface protein subunit vaccines and to natural infection by lyme disease spirochetes.Journal of infectious diseases,1995,171(4):909～915
9Lee Y S,Chung I S,Lee I R,et al.Activation of multiple effector pathways of immune system by the antimeoplastic immunostimulator acidicpolysaccharide ginsan isolated from Panax ginseng.Anticancer Res.,1997,17:323
10James M,Burns JR,Patrici DD,et al.Protective immunity against plamodium yoelii malaria induced by immunixzation with particulate blood-stage antigens.Infection and immunity,1997,65(8):3 138～3 145
7Meyding-Lamade U,Haas J,Lamade W,et al.Herpes simplex virus encephalitis:Long-term comparative study of viral load and the expression of immunology nitric oxide synthase in mouse brain tissue[J].Neuro Letters,1998;244:9-12.
8Whitley RJ,Gnann JW.Viral encephalitis:familiar infections and emerging pathogens[J].Lancet,2002;359(9305):507-513.
